跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
targeted small molecule therapeutic
首页
药物
targeted small molecule therapeutic
targeted small molecule therapeutic
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
STABILIZED PEPTIDE-MEDIATED TARGETED PROTEIN DEGRADATION
EP 3724216 A1
申请人: DANA FARBER CANCER INST INC
优先权: 2017
CN
EP
US
WO
7 件公开
Small molecules modulator of epigenetic regulation and their therapeutic applications
US 8697729 B2
申请人: CHEN LIN
优先权: 2009
US
7 件公开
MEDICAL USE OF SPLA2 HYDROLYSABLE LIPOSOMES
US 2012177726 A1
申请人: PETERSEN MORTEN JUST
优先权: 2009
EP
US
WO
5 件公开
CONJUGATE AND COMPOSITION AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF
US 20250332268 A1
申请人: SUZHOU RIBO LIFE SCIENCE CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
PAN-KRAS DEGRADING AGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF
US 20260167622 A1
申请人: LEADINGTAC PHARMACEUTICAL SHAOXING CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US 8524220 B1
申请人: BERMUDES DAVID GORDON
优先权: 2011
US
4 件公开
TARGETED CHEMICAL DRUG AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USE OF TARGETED CHEMICAL DRUG
EP 4744680 A1
申请人: BAI YAO ZHI DA BEIJING NANOBIO TECH CO LTD
优先权: 2023
CN
EP
WO
3 件公开
Targeting Pleckstrin-2 for treating cancer
US 12629424 B2
申请人: UNIV NORTHWESTERN
优先权: 2018
US
WO
3 件公开
Protease sensitivity expression system
US 8241623 B1
申请人: BERMUDES DAVID
优先权: 2010
US
3 件公开
Analogs of pituitary adenylate cyclase-activating polypeptide (PACAP) and methods for their use
US 8916517 B2
申请人: COY DAVID HOWARD
优先权: 2010
US
3 件公开
第 1 / 6 页
上一页
下一页
药物
反馈